Quality of life assessment of patients participating in phase I clinical trials during treatment (MC0115) von Atherton, P. J., Szydlo, D. W., Erlichman, C. E., Sloan, J. A.

Volltext

HER receptor signaling confers resistance to IGF-1R targeted therapy von Haluska, P., Carboni, J. M., Yu, C., Ten Eyck, C., Attar, R. M., Asmann, Y. W., Sagar, M., Wong, T. W., Gottardis, M. M., Erlichman, C. E.

Volltext

Efficacy of PS-341 in combination with paclitaxel (PAC) and carboplatin (CBDCA) for the treatment of metastatic melanoma (MM): A phase II consortium study von Maples, W. J., Suman, V., Croghan, G. A., Albertini, M. R., Linette, G., Flaherty, L. E., Eckardt, J., Amatruda, T., Erlichman, C. E.

Volltext

Gemcitabine (G) and irinotecan (CPT-11) as first-line therapy for carcinoma (ca) of unknown primary (CUP): An NCCTG phase II trial von Holtan, S. G., Foster, N. R., Erlichman, C. E., Aubry, M., Ames, M. M., Safgren, S., Steen, P. D., Morton, R. F., Graham, D., Goetz, M. P.

Volltext

Efficacy report of a multicenter phase II trial testing a biologic-only combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer (BC): A... von Holen, K. D., Mahoney, M. R., LoConte, N. K., Szydlo, D. W., Picus, J., Maples, W. J., Kim, G. P., Pitot, H. C., Philip, P. A., Thomas, J. P., Erlichman, C. E.

Volltext

A phase I study of the raf kinase/VEGF-R inhibitor sorafenib in combination with bortezomib in patients with advanced malignancy von Kumar, S., Marks, R. S., Richardson, R., Quevedo, F., Croghan, G. A., Markovic, S. N., Qin, R., Tan, A. D., Molina, J. R., Erlichman, C. E., Adjei, A. A.

Volltext

A multicenter phase 2 consortium (P2C) study of the mTOR inhibitor CCI-779 in advanced soft tissue sarcomas (STS) von Okuno, S. H., Mahoney, M. R., Bailey, H. H., Adkins, D. R., Maples, W. J., Ettinger, D., Fitch, T. R., Bot, B. M., Erlichman, C. E.

Volltext

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study von Bible, Keith C, Dr, Suman, Vera J, Prof, Molina, Julian R, MD, Smallridge, Robert C, Prof, Maples, William J, MD, Menefee, Michael E, MD, Rubin, Joseph, Prof, Sideras, Kostandinos, MD, Morris, John C, MD, McIver, Bryan, MB, Burton, Jill K, Webster, Kevin P, Bieber, Carolyn, Traynor, Anne M, MD, Flynn, Patrick J, MD, Goh, Boon Cher, MBBS, Tang, Hui, PhD, Ivy, Susan Percy, MD, Erlichman, Charles, Prof

Volltext

Reproducibility and staging of 3D human retinal organoids across multiple pluripotent stem cell lines von Capowski, Elizabeth E, Samimi, Kayvan, Mayerl, Steven J, Phillips, M Joseph, Pinilla, Isabel, Howden, Sara E, Saha, Jishnu, Jansen, Alex D, Edwards, Kimberly L, Jager, Lindsey D, Barlow, Katherine, Valiauga, Rasa, Erlichman, Zachary, Hagstrom, Anna, Sinha, Divya, Sluch, Valentin M, Chamling, Xitiz, Zack, Donald J, Skala, Melissa C, Gamm, David M

Volltext

Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study von LUBNER, Sam J, MAHONEY, Michelle R, VAN HAZEL, Guy, ERLICHMAN, Charles E, HOLEN, Kyle D, KOLESAR, Jill L, LOCONTE, Noelle K, KIM, George P, PITOT, Henry C, PHILIP, Philip A, PICUS, Joel, YONG, Wei-Peng, HORVATH, Lisa

Volltext

Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA von Estevez, Ana Y, Ganesana, Mallikarjunarao, Trentini, John F, Olson, James E, Li, Guangze, Boateng, Yvonne O, Lipps, Jennifer M, Yablonski, Sarah E R, Donnelly, William T, Leiter, James C, Erlichman, Joseph S

Volltext

A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer von HEATH, Elisabeth I, HILLMAN, David W, PILI, Roberto, CARDUCCI, Michael A, ERLICHMAN, Charles, LIU, Glenn, VAISHAMPAYAN, Ulka, SHIJIE SHENG, SARKAR, Fazlul, HARPER, Felicity, GASKINS, Melvin, PITOT, Henry C, TAN, Winston, IVY, S. Percy

Volltext

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer von Bible, Keith C, Suman, Vera J, Menefee, Michael E, Smallridge, Robert C, Molina, Julian R, Maples, William J, Karlin, Nina J, Traynor, Anne M, Kumar, Priya, Goh, Boon Cher, Lim, Wan-Teck, Bossou, Ayoko R, Isham, Crescent R, Webster, Kevin P, Kukla, Andrea K, Bieber, Carolyn, Burton, Jill K, Harris, Pamela, Erlichman, Charles, the Mayo Phase 2 Consortium and Mayo Clinic Endocrine Malignances Disease Oriented Group

Volltext

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study von Ansell, Stephen M, Prof, Tang, Hui, PhD, Kurtin, Paul J, Prof, Koenig, Patricia A, RN, Inwards, David J, MD, Shah, Keith, MD, Ziesmer, Steven C, BS, Feldman, Andrew L, MD, Rao, Radha, MD, Gupta, Mamta, PhD, Erlichman, Charles, Prof, Witzig, Thomas E, Prof

Volltext

Enterococci enhance Clostridioides difficile pathogenesis von Smith, Alexander B., Jenior, Matthew L., Keenan, Orlaith, Hart, Jessica L., Specker, Jonathan, Abbas, Arwa, Rangel, Paula C., Di, Chao, Green, Jamal, Bustin, Katelyn A., Gaddy, Jennifer A., Nicholson, Maribeth R., Laut, Clare, Kelly, Brendan J., Matthews, Megan L., Evans, Daniel R., Van Tyne, Daria, Furth, Emma E., Papin, Jason A., Bushman, Frederic D., Erlichman, Jessi, Baldassano, Robert N., Silverman, Michael A., Dunny, Gary M., Prentice, Boone M., Skaar, Eric P., Zackular, Joseph P.

Volltext

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutic... von Ma, B. B. Y., Goh, B. C., Lim, W. T., Hui, E. P., Tan, E. H., Lopes, G. de Lima, Lo, K. W., Li, L., Loong, H., Foster, N. R., Erlichman, C., King, A. D., Kam, M. K. M., Leung, S. F., Chan, K. C., Chan, A. T. C.

Volltext

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors von Wahner Hendrickson, Andrea E, Menefee, Michael E, Hartmann, Lynn C, Long, Harry J, Northfelt, Donald W, Reid, Joel M, Boakye-Agyeman, Felix, Kayode, Olumide, Flatten, Karen S, Harrell, Maria I, Swisher, Elizabeth M, Poirier, Guy G, Satele, Daniel, Allred, Jake, Lensing, Janet L, Chen, Alice, Ji, Jiuping, Zang, Yiping, Erlichman, Charles, Haluska, Paul, Kaufmann, Scott H

Volltext

Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer von ADJEI, Alex A, MAUER, Ann, VOKES, Everett E, BRUZEK, Laura, MARKS, Randolph S, HILLMAN, Shauna, GEYER, Susan, HANSON, Lorelei J, WRIGHT, John J, ERLICHMAN, Charles, KAUFMANN, Scott H

Volltext

A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H von Bible, Keith C, Suman, Vera J, Molina, Julian R, Smallridge, Robert C, Maples, William J, Menefee, Michael E, Rubin, Joseph, Karlin, Nina, Sideras, Kostandinos, Morris, John C, McIver, Bryan, Hay, Ian, Fatourechi, Vahab, Burton, Jill K, Webster, Kevin P, Bieber, Carolyn, Traynor, Anne M, Flynn, Patrick J, Cher Goh, Boon, Isham, Crescent R, Harris, Pamela, Erlichman, Charles

Volltext

A phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer von Wahner Hendrickson, A.E., Costello, B., Jewell, A., Kennedy, V., Fleming, G., Corr, B., Taylor, S.E., Lea, J., Reid, J., Swisher, E., Satele, D., Allred, J., Lensing, J., Ivy, S.P., Erlichman, C., Adjei, A.A., Kaufmann, S.

Volltext